In human GBM cell lines (U87MG and DBTRG-05MG cells), 4-AAQB notably reduced the β-catenin level and disrupted GBM-SC-associated oncogenic β-catenin/TCF-1/STAT3 signaling in a dose-dependent manner. The gene discussed is STAT3; the disease is glioblastoma.